Will a non‑live influenza vaccine administered three days ago interact with a scheduled Simponi (golimumab) dose today?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Proceed with Simponi Today - No Interaction with Recent Flu Vaccine

You can safely administer Simponi (golimumab) today without concern for interaction with the non-live influenza vaccine given 3 days ago. There is no contraindication or safety issue with this timing.

Key Points

No Safety Interaction

The FDA label for Simponi explicitly addresses vaccine interactions and only contraindicates live vaccines during TNF-blocker therapy 11. Non-live influenza vaccines are safe to administer before, during, or after Simponi treatment without any required waiting period.

Guideline Support for Continuing Immunosuppression

The 2022 American College of Rheumatology vaccination guidelines specifically address this scenario. For patients receiving TNF-blockers (which includes golimumab/Simponi) and other immunosuppressive medications:

  • Continue the immunosuppressive medication when administering influenza vaccination 22
  • The guideline explicitly states to "Continue immunosuppressive medication" for both influenza and other non-live vaccines (with the exception of methotrexate for influenza, and rituximab for non-influenza vaccines)

The Real Concern: Vaccine Efficacy, Not Safety

The actual issue is not about drug interaction or safety—it's about vaccine immunogenicity. TNF-blockers like Simponi can reduce antibody responses to influenza vaccines 345. However:

  • This reduced response is a known limitation of treating immunocompromised patients
  • The benefit of vaccination still outweighs no vaccination
  • The timing of Simponi relative to the flu vaccine (3 days apart) does not create additional safety concerns

Practical Algorithm

Proceed as follows:

  1. ✓ Administer Simponi today as scheduled
  2. ✓ Document that flu vaccine was given 3 days prior
  3. ✓ No dose adjustment or delay needed
  4. ✓ Consider the patient may have suboptimal vaccine response due to immunosuppression (not due to timing)

Important Caveats

Do NOT confuse this with live vaccines: If this were a live vaccine (e.g., MMR, varicella, live intranasal flu vaccine), you would need to avoid concurrent Simponi administration 11. The FDA label is clear that live vaccines should not be given with TNF-blockers due to risk of disseminated infection.

Timing considerations that DON'T apply here: Some guidelines recommend holding certain medications (methotrexate for 2 weeks after flu vaccine, or timing rituximab around vaccinations) to improve vaccine response 22. However, these recommendations do not apply to TNF-blockers like Simponi—the guideline explicitly states to continue these medications.

References

Related Questions

Which travel scenarios warrant administration of the seasonal inactivated influenza vaccine: (A) travel to a tropical country with an influenza outbreak, (B) group travel such as a cruise ship with passengers from multiple regions, (C) travel to a Southern Hemisphere country during its influenza season, or (D) travel to the Arabian Peninsula due to MERS?
In a patient with an arteriovenous fistula in one arm and a continuous glucose monitor on the other arm, where should the influenza vaccine be administered?
Can a patient on ixekizumab (Taltz) receive the inactivated influenza vaccine (flu shot)?
Does denosumab (Prolia) interfere with the efficacy of the influenza vaccine?
Can an afebrile patient with flu-like symptoms safely receive the inactivated influenza vaccine?
In an 8‑year‑old obese girl with loud nightly snoring, daytime sleepiness, enlarged tonsils, and polysomnography showing an obstructive apnea‑hypopnea index of 3.5 events per hour, central apnea index of 1.1 events per hour, preserved oxygenation, and mild nocturnal hypercapnia, what is the most likely diagnosis?
Is a myocardial infarction (MI) considered coronary artery disease (CAD)?
What monitor changes indicate a positive response after a 4 mL/kg mini‑fluid challenge (or passive leg raise) in a mechanically ventilated child?
Is difficulty achieving an erection, even if an erection eventually occurs, considered erectile dysfunction?
In a 38-year-old man with hypertension, gastroesophageal reflux disease, depression, and body mass index 29 kg/m², whose home sleep apnea test shows an apnea‑hypopnea index of 31 events per hour (supine 42, non‑supine 24) and an arterial oxygen saturation nadir of 89%, which of the following treatments would be most effective for his obstructive sleep apnea: hypoglossal nerve stimulator implant, auto‑adjusting positive airway pressure (APAP) 5–20 cm H₂O with mask fitting, mandibular advancement device, or injectable tirzepatide?
Do statins cause demyelination of neurons?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.